{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:43:15Z","timestamp":1794357795130,"version":"4.9.0"},"reference-count":448,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["ISF 1435\/16"],"award-info":[{"award-number":["ISF 1435\/16"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["ISF-I-CORE 1775\/12"],"award-info":[{"award-number":["ISF-I-CORE 1775\/12"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.smim.2023.101766","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T16:46:50Z","timestamp":1683046010000},"page":"101766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The biogenesis of the immunopeptidome"],"prefix":"10.1016","volume":"67","author":[{"given":"Arie","family":"Admon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2023.101766_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2019.12.005","article-title":"Cross-presentation of exogenous antigens on MHC I molecules","volume":"64","author":"Colbert","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.0105-2896.2005.00297.x","article-title":"Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing","volume":"207","author":"Li","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2023.101766_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.immuni.2005.03.009","article-title":"Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens","volume":"22","author":"Zhou","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2023.101766_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/intimm\/dxh363","article-title":"Presentation of self-antigens on MHC class II molecules during dendritic cell maturation","volume":"18","author":"Zwickey","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1146\/annurev.immunol.22.012703.104538","article-title":"Cell biology of antigen processing in vitro and in vivo","volume":"23","author":"Trombetta","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib6","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood-2003-08-2729","article-title":"Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis","volume":"103","author":"Wilson","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.smim.2023.101766_bib7","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.0501190102","article-title":"Autophagy promotes MHC class II presentation of peptides from intracellular source proteins","volume":"102","author":"Dengjel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib8","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","article-title":"Biological consequences of MHC-II expression by tumor cells in cancer","volume":"25","author":"Axelrod","year":"2019","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.smim.2023.101766_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-immunol-041015-055420","article-title":"Variations in MHC class ii antigen processing and presentation in health and disease","volume":"34","author":"Unanue","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/351290a0","article-title":"Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules","volume":"351","author":"Falk","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA class I supertypes: a revised and updated classification","volume":"9","author":"Sidney","year":"2008","journal-title":"BMC Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib12","first-page":"425","author":"Van Deutekom","year":"2015","journal-title":"Zooming into Bind. groove HLA Mol.: which Positions which Substit. Change Pept. Bind. most\u00a0?"},{"key":"10.1016\/j.smim.2023.101766_bib13","first-page":"D948","article-title":"IPD-IMGT\/HLA Database","volume":"48","author":"Robinson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.smim.2023.101766_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1877-1173(10)92003-6","article-title":"The origin and role of MHC class I-associated self-peptides","volume":"92","author":"Perreault","year":"2010","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.smim.2023.101766_bib15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib16","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00018-011-0661-2","article-title":"Generation of MHC class I ligands in the secretory and vesicular pathways","volume":"68","author":"Del Val","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.smim.2023.101766_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.autrev.2011.11.003","article-title":"Origin and plasticity of MHC I-associated self peptides","volume":"11","author":"de Verteuil","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.smim.2023.101766_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of antigen processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nchembio.1391","article-title":"A peptide\u2019s perspective on antigen presentation to the immune system","volume":"9","author":"Neefjes","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-genom-091212-153455","article-title":"Major histocompatibility complex genomics and human disease","volume":"14","author":"Trowsdale","year":"2013","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/j.smim.2023.101766_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2013.10.005","article-title":"Chemical biology of antigen presentation by MHC molecules","volume":"26","author":"van Kasteren","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0008-2015","article-title":"Antigen processing and presentation mechanisms in myeloid cells","volume":"4","author":"Roche","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.smim.2023.101766_bib24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present yourself! By MHC class i and MHC class ii molecules","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/imm.12675","article-title":"Antigen processing and immune regulation in the response to tumours","volume":"150","author":"Reeves","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.smim.2023.101766_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00251-018-1082-2","article-title":"Genetics of antigen processing and presentation","volume":"71","author":"Kelly","year":"2019","journal-title":"Immunogenetics"},{"key":"10.1016\/j.smim.2023.101766_bib27","article-title":"Variations in MHC class I antigen presentation and immunopeptidome selection pathways","volume":"9","author":"Zaitoua","year":"2020","journal-title":"F1000Research"},{"key":"10.1016\/j.smim.2023.101766_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-biophys-121219-081643","article-title":"Multifunctional chaperone and quality control complexes in adaptive immunity","volume":"49","author":"Trowitzsch","year":"2020","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.smim.2023.101766_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202000143","article-title":"Know thy immune self and non-self: Proteomics informs on the expanse of self and non-self, and how and where they arise.","volume":"21","author":"Joyce","year":"2021","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.coi.2021.04.012","article-title":"Dynamics of MHC-I molecules in the antigen processing and presentation pathway","volume":"70","author":"Truong","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coi.2021.04.009","article-title":"Major histocompatibility complex (MHC) class I and class II proteins: impact of polymorphism on antigen presentation","volume":"70","author":"Abualrous","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100230","article-title":"MHC class i immunopeptidome: past, present, and future","volume":"21","author":"Yewdell","year":"2022","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib34","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3389\/fimmu.2018.01716","article-title":"Predicting antigen presentation-what could we learn from a million peptides?","volume":"9","author":"Gfeller","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101727","article-title":"The impact of immunopeptidomics: from basic research to clinical implementation","volume":"66","author":"Shapiro","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101708","article-title":"Contemplating immunopeptidomes to better predict them","volume":"66","author":"Gfeller","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib37","doi-asserted-by":"crossref","first-page":"1097871","DOI":"10.3389\/fimmu.2022.1097871","article-title":"Immunogenic self-peptides - the great unknowns in autoimmunity: Identifying T-cell epitopes driving the autoimmune response in autoimmune diseases","volume":"13","author":"Prinz","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coi.2016.03.004","article-title":"The melting pot of the MHC II peptidome","volume":"40","author":"Stern","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101730","article-title":"Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example","volume":"66","author":"Lichti","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib40","doi-asserted-by":"crossref","first-page":"1107266","DOI":"10.3389\/fimmu.2023.1107266","article-title":"Challenges and opportunities in analyzing and modeling peptide presentation by HLA-II proteins","volume":"14","author":"ElAbd","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2005.00309.x","article-title":"The seven dirty little secrets of major histocompatibility complex class I antigen processing","volume":"207","author":"Yewdell","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2023.101766_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri2368","article-title":"The known unknowns of antigen processing and presentation.","volume":"8","author":"Vyas","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.humimm.2019.03.004","article-title":"ERAP1 shapes just part of the immunopeptidome","volume":"80","author":"Admon","year":"2019","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100099","article-title":"Are there indeed spliced peptides in the immunopeptidome","author":"Admon","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature24627","article-title":"Structure of the human MHC-I peptide-loading complex","volume":"551","author":"Blees","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib46","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.4049\/jimmunol.1501515","article-title":"Mechanistic basis for epitope proofreading in the peptide-loading complex","volume":"195","author":"Fleischmann","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib47","doi-asserted-by":"crossref","first-page":"19085","DOI":"10.1038\/srep19085","article-title":"Molecular mechanism of peptide editing in the tapasin-MHC I complex","volume":"6","author":"Fisette","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2023.101766_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-3-030-28151-9_10","article-title":"Structure and function of molecular chaperones that govern immune peptide loading","volume":"93","author":"Margulies","year":"2019","journal-title":"Subcell. Biochem"},{"key":"10.1016\/j.smim.2023.101766_bib49","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.4049\/jimmunol.171.10.5287","article-title":"Tapasin is a facilitator, not an editor, of class I MHC peptide binding.","volume":"171","author":"Zarling","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib50","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1073\/pnas.94.5.1896","article-title":"Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome","volume":"94","author":"Hughes","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2023.101766_bib51","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/j.celrep.2018.08.041","article-title":"Innate immune signals induce anterograde endosome transport promoting MHC class I cross-presentation","volume":"24","author":"Weimershaus","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.smim.2023.101766_bib52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/imr.12424","article-title":"Intracellular recycling and cross-presentation by MHC class I molecules","volume":"272","author":"van Endert","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2023.101766_bib53","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.3389\/fimmu.2018.03098","article-title":"Endocytic recycling of MHC class i molecules in non-professional antigen presenting and dendritic cells","volume":"9","author":"Montealegre","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib54","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1073\/pnas.89.22.10658","article-title":"A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity","volume":"89","author":"Mage","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.leukres.2006.06.008","article-title":"Soluble HLA revisited","volume":"31","author":"Tabayoyong","year":"2007","journal-title":"Leuk. Res"},{"key":"10.1016\/j.smim.2023.101766_bib56","doi-asserted-by":"crossref","first-page":"1069635","DOI":"10.3389\/fonc.2022.1069635","article-title":"Soluble HLA peptidome: a new resource for cancer biomarkers","volume":"12","author":"Tanuwidjaya","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.smim.2023.101766_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-981-13-9367-9_2","article-title":"MHC molecules, T cell receptors, natural killer cell receptors, and viral immunoevasins-key elements of adaptive and innate immunity","volume":"1172","author":"Jiang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0161-5890(02)00104-9","article-title":"Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes","volume":"39","author":"Del-Val","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib59","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nbt1207-1383","article-title":"Systems biology and the host response to viral infection","volume":"25","author":"Tan","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrc3670","article-title":"Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy","volume":"14","author":"Coulie","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.smim.2023.101766_bib61","article-title":"Translating immunopeptidomics to immunotherapy - decision making for patient and personalized target selection","volume":"18","author":"Fritsche","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib62","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.R120.002309","article-title":"The peptide vaccine of the future","volume":"20","author":"Nelde","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41577-020-0390-6","article-title":"A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion","volume":"21","author":"Dersh","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib64","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coi.2014.08.005","article-title":"Molecular mechanisms for contribution of MHC molecules to autoimmune diseases","volume":"31","author":"Sollid","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib65","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1615\/CritRevImmunol.2015014510","article-title":"MHC genes linked to autoimmune disease","volume":"35","author":"Deitiker","year":"2015","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri.2017.143","article-title":"HLA variation and disease","volume":"18","author":"Dendrou","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib67","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib68","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1098\/rstb.2011.0275","article-title":"Evolution, revolution and heresy in the genetics of infectious disease susceptibility.","volume":"367","author":"Hill","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"10.1016\/j.smim.2023.101766_bib69","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.tig.2020.01.008","article-title":"Advances in the evolutionary understanding of MHC polymorphism","volume":"36","author":"Radwan","year":"2020","journal-title":"Trends Genet"},{"key":"10.1016\/j.smim.2023.101766_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev-genet-080320-010449","article-title":"The awesome power of human genetics of infectious disease","volume":"56","author":"Gibbs","year":"2022","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.smim.2023.101766_bib71","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.tig.2020.10.001","article-title":"Self-peptidome variation shapes individual immune responses","volume":"37","author":"Pontarotti","year":"2021","journal-title":"Trends Genet"},{"key":"10.1016\/j.smim.2023.101766_bib72","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41586-022-05349-x","article-title":"Evolution of immune genes is associated with the Black Death","volume":"611","author":"Klunk","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1074\/mcp.R119.001743","article-title":"The Human Immunopeptidome Project: a roadmap to predict and treat immune diseases","volume":"19","author":"Vizca\u00edno","year":"2020","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib74","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.4049\/jimmunol.1600808","article-title":"Unsupervised HLA peptidome deconvolution improves ligand prediction accuracy and predicts cooperative effects in peptide-HLA interactions","volume":"197","author":"Bassani-Sternberg","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005725","article-title":"Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity","volume":"13","author":"Bassani-Sternberg","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib76","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41587-019-0289-6","article-title":"Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes","volume":"37","author":"Racle","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib77","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00251-019-01122-z","article-title":"Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data","volume":"71","author":"Garde","year":"2019","journal-title":"Immunogenetics"},{"key":"10.1016\/j.smim.2023.101766_bib78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","article-title":"A large peptidome dataset improves HLA class I epitope prediction across most of the human population","volume":"38","author":"Sarkizova","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib79","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1172\/JCI91302","article-title":"I\u2019ve got algorithm: predicting tumor and autoimmune peptide targets for CD8+ T cells.","volume":"126","author":"Dersh","year":"2016","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.smim.2023.101766_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2014.10.012","article-title":"The nature of self for T cells-a systems-level perspective","volume":"34","author":"Granados","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib81","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1172\/JCI88590","article-title":"MHC class I-associated peptides derive from selective regions of the human genome","volume":"126","author":"Pearson","year":"2016","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.smim.2023.101766_bib82","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3389\/fimmu.2017.01367","article-title":"\u201cHotspots\u201d of antigen presentation revealed by human leukocyte antigen ligandomics for neoantigen prioritization","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib83","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.4049\/jimmunol.157.5.1823","article-title":"Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?","volume":"157","author":"Yewdell","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108815","article-title":"Most non-canonical proteins uniquely populate the proteome or immunopeptidome","volume":"34","author":"Ruiz Cuevas","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.smim.2023.101766_bib85","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.1546328","article-title":"Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry","volume":"255","author":"Hunt","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib86","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1126\/science.1319610","article-title":"Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad","volume":"256","author":"Hunt","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib87","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00018-011-0659-9","article-title":"Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands","volume":"68","author":"Mester","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.smim.2023.101766_bib88","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1074\/mcp.O115.052431","article-title":"Analysis of major histocompatibility complex (MHC) immunopeptidomes using mass spectrometry","volume":"14","author":"Caron","year":"2015","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molimm.2015.06.010","article-title":"Quantifying epitope presentation using mass spectrometry","volume":"68","author":"Croft","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coi.2016.04.005","article-title":"Mass spectrometry-based antigen discovery for cancer immunotherapy","volume":"41","author":"Bassani-Sternberg","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib91","doi-asserted-by":"crossref","first-page":"1600061","DOI":"10.1002\/pmic.201600061","article-title":"Building proteomic tool boxes to monitor MHC class I and class II peptides","volume":"17","author":"Schumacher","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700259","article-title":"The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction","volume":"18","author":"Creech","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib93","first-page":"209","article-title":"Mass spectrometry based immunopeptidomics for the discovery of cancer neoantigens","volume":"2018","author":"Bassani-Sternberg","year":"1719","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib94","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4939-8979-9_5","article-title":"High-throughput, fast, and sensitive immunopeptidomics sample processing for mass spectrometry","author":"Marino","year":"2019","journal-title":"Methods Mol. Biol., Hum. Press Inc."},{"key":"10.1016\/j.smim.2023.101766_bib95","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41596-019-0133-y","article-title":"Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics","volume":"14","author":"Purcell","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.smim.2023.101766_bib96","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1074\/mcp.C119.001652","article-title":"Guidance document: validation of a high-performance liquid chromatography-tandem mass spectrometry immunopeptidomics assay for the identification of HLA class i ligands suitable for pharmaceutical therapies","volume":"19","author":"Ghosh","year":"2020","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202070175","article-title":"The Choice of HLA-associated peptide enrichment and purification strategy affects peptide yields and creates a bias in detected sequence repertoire","volume":"20","author":"Nicastri","year":"2020","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib98","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41587-021-01038-8","article-title":"Identification of tumor antigens with immunopeptidomics","volume":"40","author":"Chong","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.883989","article-title":"The importance of being presented: target validation by immunopeptidomics for epitope-specific immunotherapies","volume":"13","author":"Becker","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103107","article-title":"caAtlas: an immunopeptidome atlas of human cancer","volume":"24","author":"Yi","year":"2021","journal-title":"IScience"},{"key":"10.1016\/j.smim.2023.101766_bib101","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/imm.12936","article-title":"Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry","volume":"154","author":"Freudenmann","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.smim.2023.101766_bib102","doi-asserted-by":"crossref","first-page":"1700177","DOI":"10.1002\/pmic.201700177","article-title":"Data-Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform","volume":"17","author":"Ritz","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib103","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1021\/acs.jproteome.9b00313","article-title":"MHCquant: automated and reproducible data analysis for immunopeptidomics","volume":"18","author":"Bichmann","year":"2019","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.smim.2023.101766_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100133","article-title":"Optimized liquid and gas phase fractionation increases HLA-peptidome coverage for primary cell and tissue samples","author":"Klaeger","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100080","article-title":"Sensitive immunopeptidomics by leveraging available large-scale Multi-HLA spectral libraries, data-independent acquisition, and MS\/MS prediction","volume":"20","author":"Pak","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.642583","article-title":"Deciphering human leukocyte antigen susceptibility maps from immunopeptidomics characterization in oncology and infections","volume":"11","author":"Juanes-Velasco","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.smim.2023.101766_bib107","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/acs.jproteome.0c00464","article-title":"Automated ligand purification platform accelerates immunopeptidome analysis by mass spectrometry","volume":"20","author":"Zhang","year":"2021","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.smim.2023.101766_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102216","article-title":"New insights and approaches for analyses of immunopeptidomes","volume":"77","author":"Illing","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib109","doi-asserted-by":"crossref","first-page":"71156","DOI":"10.7554\/eLife.71156","article-title":"A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines","volume":"11","author":"Feola","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.smim.2023.101766_bib110","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1038\/s41467-022-30867-7","article-title":"A streamlined platform for analyzing tera-scale DDA and DIA mass spectrometry data enables highly sensitive immunopeptidomics","volume":"13","author":"Xin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2023.101766_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100515","article-title":"Benchmarking bioinformatics pipelines in data-independent acquisition mass spectrometry for immunopeptidomics","volume":"22","author":"Shahbazy","year":"2023","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib112","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.csbj.2023.02.033","article-title":"Immunolyser: a web-based computational pipeline for analysing and mining immunopeptidomic data.","volume":"21","author":"Munday","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.smim.2023.101766_bib113","article-title":"Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation","volume":"22","author":"Pyke","year":"2023","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(87)90175-X","article-title":"A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3.","volume":"100","author":"Sugawara","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.smim.2023.101766_bib115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1126\/science.3194755","article-title":"Autologous peptides constitutively occupy the antigen binding site on Ia","volume":"242","author":"Buus","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib116","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00002371-199308000-00003","article-title":"Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution","volume":"14","author":"Storkus","year":"1993","journal-title":"J. Immunother. Emphas. Tumor Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib117","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.20071985","article-title":"The MHC class I peptide repertoire is molded by the transcriptome","volume":"205","author":"Fortier","year":"2008","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700251","article-title":"Comparison of the MHC I immunopeptidome repertoire of B-cell lymphoblasts using two isolation methods","volume":"18","author":"Lanoix","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib119","article-title":"Mild acid elution and MHC immunoaffinity chromatography reveal similar albeit not identical profiles of the HLA class i immunopeptidome","volume":"20","author":"Sturm","year":"2020","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.smim.2023.101766_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910503","article-title":"Acid stripping after infection improves the detection of viral HLA class i natural ligands identified by mass spectrometry","volume":"22","author":"Lorente","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.smim.2023.101766_bib121","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.1546329","article-title":"HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation","volume":"255","author":"Henderson","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib122","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4939-3341-9_14","article-title":"Approach to Understand Antigen Presentation and the Immune Response.","volume":"1394","author":"Dudek","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib123","doi-asserted-by":"crossref","first-page":"11409","DOI":"10.1021\/acs.analchem.8b02420","article-title":"Chemical derivatization strategy for extending the identification of MHC class i immunopeptides","volume":"90","author":"Chen","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.smim.2023.101766_bib124","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/14789450.2018.1509000","article-title":"Employing proteomics in the study of antigen presentation: an update","volume":"15","author":"Ramarathinam","year":"2018","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib125","article-title":"Identification of mhc peptides using mass spectrometry for neoantigen discovery and cancer vaccine development","volume":"40","author":"Chen","year":"2019","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.smim.2023.101766_bib126","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1074\/mcp.TIR119.001656","article-title":"Uncovering thousands of new peptides with sequence-mask-search hybrid de novo peptide sequencing framework","volume":"18","author":"Karunratanakul","year":"2019","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib127","article-title":"1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs","volume":"11","author":"Stopfer","year":"2021","journal-title":"Immuno-Oncol. Technol."},{"key":"10.1016\/j.smim.2023.101766_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.92","article-title":"Isolation of HLA bound peptides by immunoaffinity capture and identification by mass spectrometry","volume":"1","author":"Pandey","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.smim.2023.101766_bib129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-022-04839-2","article-title":"Deciphering the immunopeptidome in vivo reveals new tumour antigens","volume":"607","author":"Jaeger","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib130","first-page":"1","article-title":"T cell antigen discovery","author":"Joglekar","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.smim.2023.101766_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225409","article-title":"Critical review of existing MHC I immunopeptidome isolation methods","volume":"25","author":"Kuznetsov","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.smim.2023.101766_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100108","article-title":"Sensitive and quantitative detection of MHC-I displayed neoepitopes using a semiautomated workflow and TOMAHAQ mass spectrometry","volume":"20","author":"Pollock","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib133","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78589","article-title":"A high-throughput yeast display approach to profile pathogen proteomes for MHC-II binding","volume":"11","author":"Huisman","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.smim.2023.101766_bib134","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl5394","article-title":"High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape","volume":"8","author":"Obermair","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.smim.2023.101766_bib135","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.189.11.1757","article-title":"Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants","volume":"189","author":"Chen","year":"1999","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib136","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.192.12.1755","article-title":"Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo.","volume":"192","author":"Zarling","year":"2000","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib137","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.coi.2005.11.015","article-title":"Post-translational modifications of naturally processed MHC-binding epitopes","volume":"18","author":"Engelhard","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib138","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.4049\/jimmunol.0802902","article-title":"N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase.","volume":"182","author":"Ostankovitch","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib139","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1073\/pnas.0812901106","article-title":"Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes","volume":"106","author":"Petersen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib140","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00109-009-0526-4","article-title":"Post-translationally modified T cell epitopes: immune recognition and immunotherapy.","volume":"87","author":"Petersen","year":"2009","journal-title":"J. Mol. Med. (Berl. )"},{"key":"10.1016\/j.smim.2023.101766_bib141","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1101892108","article-title":"An antigenic peptide produced by reverse splicing and double asparagine deamidation.","volume":"108","author":"Dalet","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib142","doi-asserted-by":"crossref","first-page":"203ra125","DOI":"10.1126\/scitranslmed.3006061","article-title":"MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia","volume":"5","author":"Cobbold","year":"2013","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.smim.2023.101766_bib143","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1038\/ncomms13404","article-title":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry","volume":"7","author":"Bassani-Sternberg","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2023.101766_bib144","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1021\/acs.jproteome.6b00496","article-title":"Identification and characterization of complex glycosylated peptides presented by the MHC class ii processing pathway in melanoma","volume":"16","author":"Malaker","year":"2017","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.smim.2023.101766_bib145","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1158\/2326-6066.CIR-16-0280","article-title":"Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia","volume":"5","author":"Malaker","year":"2017","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.smim.2023.101766_bib146","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/mcp.TIR119.001641","article-title":"Mass spectrometry based immunopeptidomics leads to robust predictions of phosphorylated HLA class I ligands","volume":"19","author":"Solleder","year":"2020","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib147","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41571-020-0387-x","article-title":"Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire","volume":"17","author":"Haen","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.smim.2023.101766_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100112","article-title":"MHC phosphopeptides: promising targets for immunotherapy of cancer and other chronic diseases","volume":"20","author":"Mahoney","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910800","article-title":"Ubiquitination in T-cell activation and checkpoint inhibition: new avenues for targeted cancer immunotherapy","volume":"22","author":"Gavali","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.smim.2023.101766_bib150","article-title":"Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors","author":"Kacen","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib151","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1084\/jem.20051251","article-title":"The insulin A-chain epitope recognized by human T cells is posttranslationally modified.","volume":"202","author":"Mannering","year":"2005","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib152","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.RA119.001846","article-title":"Immunopeptidomic analysis reveals that deamidated HLA-bound peptides arise predominantly from deglycosylated precursors","volume":"19","author":"Mei","year":"2020","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib153","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg2482","article-title":"Cysteine carboxyethylation generates neoantigens to induce HLA-restricted autoimmunity","volume":"379","author":"Zhai","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib154","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nmeth1019","article-title":"Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry","volume":"4","author":"Elias","year":"2007","journal-title":"Nat. Methods"},{"issue":"Suppl 1","key":"10.1016\/j.smim.2023.101766_bib155","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2105-13-S16-S2","article-title":"False discovery rates in spectral identification","volume":"13","author":"Jeong","year":"2012","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.smim.2023.101766_bib156","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1074\/mcp.M114.046995","article-title":"A scalable approach for protein false discovery rate estimation in large proteomic data sets","volume":"14","author":"Savitski","year":"2015","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib157","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s42485-021-00066-x","article-title":"Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I.","volume":"12","author":"Mangalaparthi","year":"2021","journal-title":"J. Proteins Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib158","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1021\/pr101060v","article-title":"More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS\/MS","volume":"10","author":"Michalski","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.smim.2023.101766_bib159","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700464","article-title":"In immunopeptidomics we need a sniper instead of a shotgun","volume":"18","author":"Faridi","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib160","doi-asserted-by":"crossref","first-page":"10757","DOI":"10.1021\/acs.analchem.6b03409","article-title":"Distinguishing between Leucine and Isoleucine by Integrated LC-MS Analysis Using an Orbitrap Fusion Mass Spectrometer","volume":"88","author":"Xiao","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.smim.2023.101766_bib161","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1021\/ac501200h","article-title":"Discrimination of leucine and isoleucine in peptides sequencing with Orbitrap Fusion mass spectrometer","volume":"86","author":"Lebedev","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.smim.2023.101766_bib162","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/2326-6066.CIR-21-0727","article-title":"Navigating critical challenges associated with immunopeptidomics-based detection of proteasomal spliced peptide candidates","volume":"10","author":"Lichti","year":"2022","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.smim.2023.101766_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.847756","article-title":"Unsupervised mining of HLA-I peptidomes reveals new binding motifs and potential false positives in the community database","volume":"13","author":"Sricharoensuk","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib164","article-title":"Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification","author":"Bulik-Sullivan","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800357","article-title":"MS-Rescue: a computational pipeline to increase the quality and yield of immunopeptidomics experiments","volume":"19","author":"Andreatta","year":"2019","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib166","article-title":"DeepRescore: leveraging deep learning to improve peptide identification in immunopeptidomics","author":"Li","year":"2020","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib167","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1038\/s41467-021-23713-9","article-title":"Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics","volume":"12","author":"Wilhelm","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2023.101766_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34904-3","article-title":"AlphaPeptDeep: a modular deep learning framework to predict peptide properties for proteomics","volume":"13","author":"Zeng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2023.101766_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100266","article-title":"MS2Rescore: data-driven rescoring dramatically boosts immunopeptide identification rates","volume":"21","author":"Declercq","year":"2022","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100432","article-title":"inSPIRE: an open-source tool for increased mass spectrometry identification rates using prosit spectral prediction","volume":"21","author":"Cormican","year":"2022","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib171","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41587-022-01424-w","article-title":"Prediction of peptide mass spectral libraries with machine learning","volume":"41","author":"Cox","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib172","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/2326-6066.CIR-19-0886","article-title":"Identification of the Cryptic HLA-I Immunopeptidome","volume":"8","author":"Erhard","year":"2020","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.smim.2023.101766_bib173","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/acs.jproteome.8b00875","article-title":"Identification of hybrid insulin peptides (HIPs) in mouse and human islets by mass spectrometry","volume":"18","author":"Wiles","year":"2019","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.smim.2023.101766_bib174","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1074\/mcp.TIR117.000383","article-title":"High-throughput and Sensitive Immunopeptidomics platform reveals profound interferon\u03b3-mediated remodeling of the human leukocyte antigen (HLA) ligandome","volume":"17","author":"Chong","year":"2018","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib175","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.RA119.001876","article-title":"Identification of tumor antigens in the HLA peptidome of patient-derived xenograft tumors in mouse","volume":"19","author":"Rijensky","year":"2020","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib176","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41467-020-14968-9","article-title":"Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes","volume":"11","author":"Chong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2023.101766_bib177","first-page":"15","article-title":"Database of T cell-defined human tumor antigens: the 2013 update","volume":"13","author":"Vigneron","year":"2013","journal-title":"Cancer Immun."},{"key":"10.1016\/j.smim.2023.101766_bib178","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib179","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-immunol-042617-053402","article-title":"Cancer neoantigens","volume":"37","author":"Schumacher","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib180","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib181","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.18632\/oncotarget.6960","article-title":"Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens","volume":"7","author":"Kalaora","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.smim.2023.101766_bib182","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1158\/0008-5472.CAN-22-1525","article-title":"Boosting Antitumor Immunity with an Expanded Neoepitope Landscape","volume":"82","author":"Nagel","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.smim.2023.101766_bib183","article-title":"Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection","volume":"5","author":"Ebrahimi-Nik","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.smim.2023.101766_bib184","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s40425-019-0769-8","article-title":"Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.","volume":"7","author":"Newey","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2023.101766_bib185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib186","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fimmu.2020.00027","article-title":"Computational prediction and validation of tumor-associated neoantigens","volume":"11","author":"Roudko","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib187","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190179","article-title":"Mutation position is an important determinant for predicting cancer neoantigens","volume":"217","author":"Capietto","year":"2020","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib188","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ccell.2022.07.005","article-title":"A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy","volume":"40","author":"Zhang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.smim.2023.101766_bib189","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","article-title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines","volume":"18","author":"Blass","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.smim.2023.101766_bib190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s43018-021-00210-y","article-title":"Targeting public neoantigens for cancer immunotherapy","volume":"2","author":"Pearlman","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.smim.2023.101766_bib191","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41587-021-01072-6","article-title":"Sensitive identification of neoantigens and cognate TCRs in human solid tumors","volume":"40","author":"Arnaud","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib192","doi-asserted-by":"crossref","first-page":"18558","DOI":"10.1038\/s41598-019-54700-2","article-title":"Murine xenograft bioreactors for human immunopeptidome discovery","volume":"9","author":"Heather","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2023.101766_bib193","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.157","article-title":"A tissue-based draft map of the murine MHC class I immunopeptidome","volume":"5","author":"Schuster","year":"2018","journal-title":"Sci. Data."},{"key":"10.1016\/j.smim.2023.101766_bib194","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002071","article-title":"HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.","volume":"9","author":"Marcu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2023.101766_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103768","article-title":"Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues","volume":"25","author":"Kubiniok","year":"2022","journal-title":"IScience"},{"key":"10.1016\/j.smim.2023.101766_bib196","doi-asserted-by":"crossref","first-page":"eabo6135","DOI":"10.1126\/scitranslmed.abo6135","article-title":"Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy","volume":"14","author":"Kim","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2023.101766_bib197","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.smim.2023.101766_bib198","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The Immune Epitope Database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.smim.2023.101766_bib199","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.smim.2023.101766_bib200","doi-asserted-by":"crossref","first-page":"D1237","DOI":"10.1093\/nar\/gkx664","article-title":"The SysteMHC Atlas project","volume":"46","author":"Shao","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.smim.2023.101766_bib201","article-title":"dbPepNeo: a manually curated database for human tumor neoantigen peptides","volume":"2020","author":"Tan","year":"2020","journal-title":"Database (Oxf. )"},{"key":"10.1016\/j.smim.2023.101766_bib202","article-title":"dbPepNeo2.0: a database for human tumor neoantigen peptides from mass spectrometry and TCR recognition","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib203","doi-asserted-by":"crossref","first-page":"D845","DOI":"10.1093\/nar\/gkac902","article-title":"The cancer epitope database and analysis resource (CEDAR)","volume":"51","author":"Ko\u015falo\u011flu-Yal\u00e7\u0131n","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.smim.2023.101766_bib204","doi-asserted-by":"crossref","first-page":"D409","DOI":"10.1093\/nar\/gkac776","article-title":"IEAtlas: an atlas of HLA-presented immune epitopes derived from non-coding regions","volume":"51","author":"Cai","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.smim.2023.101766_bib205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0952-7915(99)80035-1","article-title":"Description and prediction of peptide-MHC binding: the \u201chuman MHC project\u201d","volume":"11","author":"Buus","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib206","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.O111.011833","article-title":"The human immunopeptidome project, a suggestion for yet another postgenome next big thing","volume":"10","author":"Admon","year":"2011","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib207","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.immuni.2017.07.010","article-title":"A case for a human immuno-peptidome project consortium","volume":"47","author":"Caron","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2023.101766_bib208","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1073\/pnas.1008501107","article-title":"Soluble plasma HLA peptidome as a potential source for cancer biomarkers","volume":"107","author":"Bassani-Sternberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2023.101766_bib209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pmic.201600364","article-title":"Purification of soluble HLA class I complexes from human serum or plasma deliver high quality immuno peptidomes required for biomarker discovery","volume":"17","author":"Ritz","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib210","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1074\/mcp.RA119.001524","article-title":"Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma","volume":"18","author":"Shraibman","year":"2019","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib211","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700246","article-title":"Membranal and blood-soluble HLA class ii peptidome analyses using data-dependent and independent acquisition","volume":"18","author":"Ritz","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib212","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003733","article-title":"Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigens.","volume":"10","author":"Khazan-Kost","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2023.101766_bib213","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/348252a0","article-title":"Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells","volume":"348","author":"R\u00f6tzschke","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib214","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/JVI.05737-11","article-title":"Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.","volume":"86","author":"Lorente","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2023.101766_bib215","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1074\/mcp.M114.045401","article-title":"The viral transcription group determines the HLA class i cellular immune response against human respiratory syncytial virus","volume":"14","author":"Johnstone","year":"2015","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib216","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/(SICI)1521-4141(200004)30:4<1172::AID-IMMU1172>3.0.CO;2-J","article-title":"A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains","volume":"30","author":"van Els","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib217","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1128\/JVI.03627-14","article-title":"Early kinetics of the HLA class i-associated peptidome of MVA.HIVconsv-infected cells","volume":"89","author":"Ternette","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2023.101766_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2020.103759","article-title":"The HLA-DP peptide repertoire from human respiratory syncytial virus is focused on major structural proteins with the exception of the viral polymerase","volume":"221","author":"Lorente","year":"2020","journal-title":"J. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib219","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","article-title":"SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition","volume":"22","author":"Nelde","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib220","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1016\/j.cell.2021.05.046","article-title":"Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.","volume":"184","author":"Weingarten-Gabbay","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.smim.2023.101766_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109305","article-title":"Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics","volume":"35","author":"Nagler","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.smim.2023.101766_bib222","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","article-title":"Identification of bacteria-derived HLA-bound peptides in melanoma","volume":"592","author":"Kalaora","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib223","article-title":"Benchmarking the human leukocyte antigen typing performance of three assays and seven next-generation sequencing-based algorithms","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib224","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.987655","article-title":"Benchmarking freely available HLA typing algorithms across varying genes, coverages and typing resolutions","volume":"13","author":"Thuesen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib225","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.176.6.1681","article-title":"Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.","volume":"176","author":"Corr","year":"1992","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib226","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00251-004-0647-4","article-title":"Definition of supertypes for HLA molecules using clustering of specificity matrices","volume":"55","author":"Lund","year":"2004","journal-title":"Immunogenetics"},{"key":"10.1016\/j.smim.2023.101766_bib227","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/bioinformatics\/bts621","article-title":"Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach","volume":"29","author":"Andreatta","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.smim.2023.101766_bib228","first-page":"D344","article-title":"GibbsCluster: unsupervised clustering and alignment of peptide sequences","volume":"41","author":"Andreatta","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.smim.2023.101766_bib229","article-title":"NNAlign_MA; MHC peptidome deconvolution for accurate MHC binding motif characterization and improved T cell epitope predictions.","volume":"172","author":"Alvarez","year":"2019","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib230","first-page":"2401","article-title":"Recent progress on MHC-I epitope prediction in tumor immunotherapy","volume":"11","author":"Wang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.smim.2023.101766_bib231","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/imm.13279","article-title":"Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA-DQ2.5","volume":"162","author":"Ko\u015falo\u011flu-Yal\u00e7\u0131n","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.smim.2023.101766_bib232","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s002510050219","article-title":"Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501","volume":"45","author":"Prilliman","year":"1997","journal-title":"Immunogenetics"},{"key":"10.1016\/j.smim.2023.101766_bib233","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/1521-4141(200201)32:1<213::AID-IMMU213>3.0.CO;2-8","article-title":"Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens","volume":"32","author":"Barnea","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib234","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.4049\/jimmunol.172.5.2944","article-title":"Toward a definition of self: proteomic evaluation of the class I peptide repertoire.","volume":"172","author":"Hickman","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00251-003-0570-0","article-title":"Large-scale analysis of HLA peptides presented by HLA-Cw4","volume":"55","author":"Buchsbaum","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.smim.2023.101766_bib236","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.27257","article-title":"The HLA-B*2705 peptidome","volume":"62","author":"Ben Dror","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2023.101766_bib237","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.molimm.2012.02.117","article-title":"Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands","volume":"51","author":"Scull","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib238","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.imlet.2015.03.008","article-title":"Efficient peptide recovery from secreted recombinant MHC-I molecules expressed via mRNA transfection","volume":"165","author":"Lazarus","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.smim.2023.101766_bib239","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0092-8674(78)90296-9","article-title":"Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis","volume":"14","author":"Barnstable","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.smim.2023.101766_bib240","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0198-8859(00)00216-0","article-title":"C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells","volume":"61","author":"Hickman","year":"2000","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib241","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658372","article-title":"ARTEMIS: a novel mass-spec platform for HLA-restricted self and disease-associated peptide discovery","volume":"12","author":"Finton","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib242","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.immuni.2019.08.012","article-title":"Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction","volume":"51","author":"Abelin","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2023.101766_bib243","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0092-8674(90)90512-D","article-title":"Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders","volume":"63","author":"Hammer","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.smim.2023.101766_bib244","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1074\/mcp.M116.066241","article-title":"The Human Leukocyte Antigen (HLA)-B27 peptidome in vivo, in spondyloarthritis-susceptible HLA-B27 transgenic rats and the effect of erap1 deletion","volume":"16","author":"Barnea","year":"2017","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib245","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.0001-2815.2004.00243.x","article-title":"Humanized animal models for autoimmune diseases","volume":"63","author":"Gregersen","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.smim.2023.101766_bib246","doi-asserted-by":"crossref","first-page":"33612","DOI":"10.1038\/srep33612","article-title":"Improved transgenic mouse model for studying HLA class i antigen presentation","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2023.101766_bib247","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2017.02.007","article-title":"Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction","volume":"46","author":"Abelin","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2023.101766_bib248","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1087057108329453","article-title":"Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays.","volume":"14","author":"Harndahl","year":"2009","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.smim.2023.101766_bib249","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-MHC class i interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jim.2016.02.016","article-title":"Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes.","volume":"432","author":"Hellman","year":"2016","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.smim.2023.101766_bib251","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700252","article-title":"Computational tools for the identification and interpretation of sequence motifs in immunopeptidomes","volume":"18","author":"Alvarez","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib252","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.smim.2023.101766_bib253","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci."},{"key":"10.1016\/j.smim.2023.101766_bib254","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/imm.12763","article-title":"Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules","volume":"152","author":"Andreatta","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.smim.2023.101766_bib255","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1074\/mcp.M200046-MCP200","article-title":"Dynamics of protein turnover, a missing dimension in proteomics","volume":"1","author":"Pratt","year":"2002","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib256","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1074\/mcp.M500241-MCP200","article-title":"The turnover kinetics of major histocompatibility complex peptides of human cancer cells","volume":"5","author":"Milner","year":"2006","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib257","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1074\/mcp.M112.026013","article-title":"The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome","volume":"12","author":"Milner","year":"2013","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib258","doi-asserted-by":"crossref","first-page":"E1591","DOI":"10.1073\/pnas.1321902111","article-title":"The nature and extent of contributions by defective ribosome products to the HLA peptidome","volume":"111","author":"Bourdetsky","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100105","article-title":"The effect of interferons on presentation of defective ribosome products as HLA peptides","author":"Komov","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib260","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nbt947","article-title":"Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling","volume":"22","author":"Lemmel","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib261","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1038\/s41467-020-16588-9","article-title":"Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4\/6 inhibition","volume":"11","author":"Stopfer","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2023.101766_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100110","article-title":"Pitfalls in HLA ligandomics-how to catch a li(e)gand","volume":"20","author":"Fritsche","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib263","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111173118","article-title":"Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants","volume":"118","author":"Stopfer","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib264","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00262-004-0592-y","article-title":"Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members","volume":"54","author":"Hogan","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.smim.2023.101766_bib265","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700390","article-title":"Strategy for low-abundant HLA class-i-presented peptide detection identifies novel human papillomavirus T-Cell epitopes","volume":"18","author":"Blatnik","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib266","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/pmic.201000531","article-title":"Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring","volume":"11","author":"Tan","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib267","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/acs.jproteome.1c00842","article-title":"HLA Allele-specific quantitative profiling of type 1 Diabetic B lymphocyte immunopeptidome.","volume":"21","author":"Sudhir","year":"2022","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.smim.2023.101766_bib268","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1074\/mcp.M114.042812","article-title":"Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation","volume":"14","author":"Bassani-Sternberg","year":"2015","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib269","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1074\/mcp.M116.060350","article-title":"Human Leukocyte Antigen (HLA) peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy","volume":"15","author":"Shraibman","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood-2012-02-412593","article-title":", MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements","volume":"119","author":"Granados","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.smim.2023.101766_bib271","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1074\/mcp.M600310-MCP200","article-title":"Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface","volume":"6","author":"Weinzierl","year":"2007","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib272","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002517","article-title":"Proteome sampling by the HLA class I antigen processing pathway","volume":"8","author":"Hoof","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib273","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3389\/fimmu.2018.01538","article-title":"A mechanistic model for predicting cell surface presentation of competing peptides by MHC class i molecules","volume":"9","author":"Boulanger","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib274","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nri1250","article-title":"Making sense of mass destruction: quantitating MHC class I antigen presentation","volume":"3","author":"Yewdell","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib275","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/CBI20110055","article-title":"Out with the old, in with the new? Comparing methods for measuring protein degradation","volume":"35","author":"Yewdell","year":"2011","journal-title":"Cell Biol. Int"},{"key":"10.1016\/j.smim.2023.101766_bib276","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41587-021-01021-3","article-title":"Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer","volume":"40","author":"Ouspenskaia","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib277","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35008096","article-title":"Rapid degradation of a large fraction of newly synthesized proteins by proteasomes","volume":"404","author":"Schubert","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib278","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1182\/blood-2012-04-420810","article-title":"All roads lead to \u201come\u201d: defining the DRiPome","volume":"119","author":"Yewdell","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.smim.2023.101766_bib279","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.it.2014.01.002","article-title":"Re-examining class-I presentation and the DRiP hypothesis","volume":"35","author":"Rock","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib280","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1074\/jbc.M509126200","article-title":"Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control","volume":"281","author":"Qian","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2023.101766_bib281","article-title":"Immunoribosomes: where\u2019s there\u2019s fire, there\u2019s fire","author":"Wei","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib282","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41580-019-0118-2","article-title":"Mechanisms and functions of ribosome-associated protein quality control","volume":"20","author":"Joazeiro","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.smim.2023.101766_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2018.12.020","article-title":"Ribosomal proteins regulate MHC class i peptide generation for immunosurveillance","author":"Wei","year":"2019","journal-title":"Mol. Cell."},{"key":"10.1016\/j.smim.2023.101766_bib284","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1914401117","article-title":"Role for ribosome-associated quality control in sampling proteins for MHC class I-mediated antigen presentation","volume":"117","author":"Trentini","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib285","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1073\/pnas.0910997107","article-title":"Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action","volume":"107","author":"Lev","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib286","doi-asserted-by":"crossref","first-page":"15407","DOI":"10.1073\/pnas.1208696109","article-title":"Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters","volume":"109","author":"Lu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib287","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1189\/jlb.1113599","article-title":"Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors.","volume":"95","author":"Ant\u00f3n","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib288","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tcb.2019.09.004","article-title":"Peptide channeling: the key to MHC class i immunosurveillance?","volume":"29","author":"Yewdell","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.smim.2023.101766_bib289","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1586\/14760584.2013.836911","article-title":"HLA ligandome tumor antigen discovery for personalized vaccine approach","volume":"12","author":"Rammensee","year":"2013","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.smim.2023.101766_bib290","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-pharmtox-011112-140326","article-title":"Cause and consequence of cancer\/testis antigen activation in cancer","volume":"54","author":"Whitehurst","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.smim.2023.101766_bib291","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.semcancer.2021.04.016","article-title":"Cancer\/testis antigens: from serology to mRNA cancer vaccine","volume":"76","author":"Fan","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.smim.2023.101766_bib292","doi-asserted-by":"crossref","first-page":"15772","DOI":"10.18632\/oncotarget.4694","article-title":"Oncogenic cancer\/testis antigens: prime candidates for immunotherapy","volume":"6","author":"Gjerstorff","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.smim.2023.101766_bib293","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.semcancer.2018.08.006","article-title":"Cancer-testis antigens: unique cancer stem cell biomarkers and targets for cancer therapy","volume":"53","author":"Gordeeva","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.smim.2023.101766_bib294","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12859-021-03962-7","article-title":"TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes","volume":"22","author":"Zhang","year":"2021","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.smim.2023.101766_bib295","doi-asserted-by":"crossref","first-page":"10499","DOI":"10.1038\/ncomms10499","article-title":"Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types","volume":"7","author":"Wang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2023.101766_bib296","doi-asserted-by":"crossref","first-page":"92966","DOI":"10.18632\/oncotarget.21715","article-title":"Genome-wide identification of cancer\/testis genes and their association with prognosis in a pan-cancer analysis","volume":"8","author":"da Silva","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.smim.2023.101766_bib297","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1038\/s41388-018-0357-2","article-title":"Massive expression of germ cell-specific genes is a hallmark of cancer and a potential target for novel treatment development","volume":"37","author":"Bruggeman","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.smim.2023.101766_bib298","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12434","article-title":"Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance","volume":"272","author":"Starck","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2023.101766_bib299","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1038\/ncomms10238","article-title":"Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames","volume":"7","author":"Laumont","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2023.101766_bib300","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00018-017-2628-4","article-title":"Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy","volume":"75","author":"Laumont","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.smim.2023.101766_bib301","doi-asserted-by":"crossref","first-page":"eaau5516","DOI":"10.1126\/scitranslmed.aau5516","article-title":"Noncoding regions are the main source of targetable tumor-specific antigens","volume":"10","author":"Laumont","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2023.101766_bib302","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/2326-6066.CIR-19-0541","article-title":"Proteogenomics uncovers a vast repertoire of shared tumor-specific antigens in ovarian cancer","volume":"8","author":"Zhao","year":"2020","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.smim.2023.101766_bib303","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08890","article-title":"Many lncRNAs, 5\u2032UTRs, and pseudogenes are translated and some are likely to express functional proteins","volume":"4","author":"Ji","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.smim.2023.101766_bib304","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tips.2021.01.006","article-title":"RNA dysregulation: an expanding source of cancer immunotherapy targets","volume":"42","author":"Pan","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.smim.2023.101766_bib305","article-title":"The potential regulatory roles of circular RNAs in tumor immunology and immunotherapy","volume":"11","author":"Fang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib306","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03528","article-title":"Extensive translation of small open reading frames revealed by Poly-Ribo-Seq","volume":"3","author":"Aspden","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.smim.2023.101766_bib307","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm.4289","article-title":"Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes","volume":"23","author":"Kracht","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2023.101766_bib308","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-020-03054-1","article-title":"Anti-tumour immunity induces aberrant peptide presentation in melanoma","volume":"590","author":"Bartok","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib309","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102389","article-title":"NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes","volume":"24","author":"Becker","year":"2021","journal-title":"IScience"},{"key":"10.1016\/j.smim.2023.101766_bib310","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nbt.4239","article-title":"Intron retention is a source of neoepitopes in cancer","volume":"36","author":"Smart","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.smim.2023.101766_bib311","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008692","article-title":"The synthesis of truncated polypeptides for immune surveillance and viral evasion","volume":"5","author":"Cardinaud","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2023.101766_bib312","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1084\/jem.184.4.1319","article-title":"Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames.","volume":"184","author":"Bullock","year":"1996","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib313","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20011399","article-title":"+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10.","volume":"195","author":"Saulquin","year":"2002","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib314","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1073\/pnas.1402670111","article-title":"Cryptic MHC class I-binding peptides are revealed by aminoglycoside-induced stop codon read-through into the 3\u2019 UTR","volume":"111","author":"Goodenough","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2023.101766_bib315","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1126\/science.1085650","article-title":"Constitutive display of cryptic translation products by MHC class I molecules","volume":"301","author":"Schwab","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib316","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003460","article-title":"A distinct translation initiation mechanism generates cryptic peptides for immune surveillance","volume":"3","author":"Starck","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2023.101766_bib317","doi-asserted-by":"crossref","first-page":"aad3867","DOI":"10.1126\/science.aad3867","article-title":"Translation from the 5\u2019 untranslated region shapes the integrated stress response.","volume":"351","author":"Starck","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib318","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1038\/s41467-018-06405-9","article-title":"RNA editing derived epitopes function as cancer antigens to elicit immune responses","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2023.101766_bib319","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.7150\/thno.35033","article-title":"Survey of the translation shifts in hepatocellular carcinoma with ribosome profiling","volume":"9","author":"Zou","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.smim.2023.101766_bib320","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cell.2010.07.022","article-title":"The pioneer round of translation: features and functions","volume":"142","author":"Maquat","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.smim.2023.101766_bib321","doi-asserted-by":"crossref","first-page":"11572","DOI":"10.1073\/pnas.1104104108","article-title":"Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation","volume":"108","author":"Apcher","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib322","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051968","article-title":"Premature translational termination products are rapidly degraded substrates for MHC class I presentation","volume":"7","author":"Lacsina","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2023.101766_bib323","doi-asserted-by":"crossref","first-page":"17951","DOI":"10.1073\/pnas.1309956110","article-title":"Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway","volume":"110","author":"Apcher","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib324","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.coi.2016.04.002","article-title":"The source of MHC class I presented peptides and its implications","volume":"40","author":"Apcher","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib325","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04499-2","article-title":"Tryptophan depletion results in tryptophan-to-phenylalanine substitutants","author":"Pataskar","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib326","doi-asserted-by":"crossref","first-page":"21170","DOI":"10.1074\/jbc.R117.807560","article-title":"Peptide splicing by the proteasome.","volume":"292","author":"Vigneron","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2023.101766_bib327","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.trecan.2017.07.007","article-title":"Learning from the proteasome how to fine-tune cancer immunotherapy","volume":"3","author":"Vigneron","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.smim.2023.101766_bib328","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.it.2017.07.011","article-title":"Post-translational peptide splicing and T cell responses","volume":"38","author":"Mishto","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib329","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coi.2018.04.016","article-title":"Why do proteases mess up with antigen presentation by re-shuffling antigen sequences","volume":"52","author":"Liepe","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molimm.2018.03.030","article-title":"Production of spliced peptides by the proteasome","volume":"113","author":"Vigneron","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib331","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100158","article-title":"Commentary: are there indeed spliced peptides in the immunopeptidome","volume":"20","author":"Mishto","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib332","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13589","article-title":"Spliced HLA-bound peptides: a Black Swan event in immunology","author":"Faridi","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib333","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.720811","article-title":"Is the Immunopeptidome Getting Darker?: A Commentary on the Discussion around Mishto et al., 2019","volume":"12","author":"Purcell","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib334","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature02240","article-title":"Immune recognition of a human renal cancer antigen through post-translational protein splicing","volume":"427","author":"Hanada","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib335","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1095522","article-title":"An antigenic peptide produced by peptide splicing in the proteasome","volume":"304","author":"Vigneron","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib336","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.1130660","article-title":"An antigen produced by splicing of noncontiguous peptides in the reverse order","volume":"313","author":"Warren","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib337","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.1302032","article-title":"A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming.","volume":"192","author":"Michaux","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib338","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar3947","article-title":"A subset of HLA-I peptides are not genomically templated: evidence for cis- and trans-spliced peptide ligands.","volume":"3","author":"Faridi","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib339","doi-asserted-by":"crossref","first-page":"eaaw1622","DOI":"10.1126\/sciimmunol.aaw1622","article-title":"Comment on A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands","volume":"4","author":"Rolfs","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib340","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw8457","article-title":"Response to Comment on \u201cA subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands\u201d.","volume":"4","author":"Faridi","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib341","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ab.2006.06.023","article-title":"Rearrangement of terminal amino acid residues in peptides by protease-catalyzed intramolecular transpeptidation","volume":"356","author":"Fodor","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.smim.2023.101766_bib342","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.4049\/jimmunol.0901277","article-title":"Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5.","volume":"184","author":"Dalet","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib343","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.aad2791","article-title":"Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion","volume":"351","author":"Delong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib344","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaut.2016.10.007","article-title":"An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse.","volume":"78","author":"Wiles","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.smim.2023.101766_bib345","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1126\/sciimmunol.aav7517","article-title":"How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes.","volume":"4","author":"Wang","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib346","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/cei.13335","article-title":"HIPs and HIP-reactive T cells","volume":"198","author":"Wiles","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib347","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192135","article-title":"Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation.","volume":"218","author":"Reed","year":"2021","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib348","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000830","article-title":"The 20S proteasome splicing activity discovered by SpliceMet","volume":"6","author":"Liepe","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib349","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/biom4040994","article-title":"Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex","volume":"4","author":"Vigneron","year":"2014","journal-title":"Biomolecules"},{"key":"10.1016\/j.smim.2023.101766_bib350","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.4049\/jimmunol.1402454","article-title":"Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage.","volume":"195","author":"Berkers","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib351","doi-asserted-by":"crossref","first-page":"24032","DOI":"10.1038\/srep24032","article-title":"Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes","volume":"6","author":"Ebstein","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2023.101766_bib352","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.2337\/db22-0303","article-title":"Cathepsin D drives the formation of hybrid insulin peptides relevant to the pathogenesis of type 1 diabetes","volume":"71","author":"Crawford","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.smim.2023.101766_bib353","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41590-020-0623-7","article-title":"The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides","volume":"21","author":"Wan","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib354","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1126\/science.aaf4384","article-title":"A large fraction of HLA class I ligands are proteasome-generated spliced peptides","volume":"354","author":"Liepe","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib355","first-page":"349","article-title":"Global Identification of post-translationally spliced peptides with neo-fusion","volume":"18","author":"Rolfs","year":"2019","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.smim.2023.101766_bib356","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100875","article-title":"RHybridFinder: An R package to process immunopeptidomic data for putative hybrid peptide discovery","volume":"2","author":"Saab","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.smim.2023.101766_bib357","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202200271","article-title":"iBench: a ground truth approach for advanced validation of mass spectrometry identification method","volume":"23","author":"Cormican","year":"2023","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib358","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1074\/mcp.RA118.000877","article-title":"Estimating the contribution of proteasomal spliced peptides to the HLA-I ligandome","volume":"17","author":"Mylonas","year":"2018","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib359","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100519","article-title":"Large-scale immunopeptidome analysis reveals recurrent posttranslational splicing of cancer- and immune-associated genes","volume":"22","author":"Levy","year":"2023","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib360","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119736119","article-title":"An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool","volume":"119","author":"Verkerk","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib361","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.3389\/fimmu.2019.02572","article-title":"An in silico-in vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients","volume":"10","author":"Mishto","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib362","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.523906","article-title":"Commentary: an in silico - in vitro pipeline identifying an HLA-A*02:01+ KRAS G12V+ spliced epitope candidate for a broad tumor-immune response in cancer patients","volume":"12","author":"Beer","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib363","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.679836","article-title":"Response: commentary: an in silico-in vitro pipeline identifying an HLA-A*02:01+ KRAS G12V+ spliced epitope candidate for a broad tumor-immune response in cancer patients","volume":"12","author":"Mishto","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib364","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-0716-0434-2_2","article-title":"Protein splicing: from the foundations to the development of biotechnological applications","volume":"2133","author":"Romero-Casa\u00f1as","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib365","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","article-title":"Proteasomal and autophagic degradation systems","volume":"86","author":"Dikic","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.smim.2023.101766_bib366","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/357375a0","article-title":"Proteolysis, proteasomes and antigen presentation","volume":"357","author":"Goldberg","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib367","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/360171a0","article-title":"Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules","volume":"360","author":"Arnold","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib368","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/365264a0","article-title":"Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes","volume":"365","author":"Gaczynska","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib369","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/363552a0","article-title":"A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation","volume":"363","author":"Michalek","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib370","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0092-8674(94)90462-6","article-title":"Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules","volume":"78","author":"Rock","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.smim.2023.101766_bib371","doi-asserted-by":"crossref","first-page":"10850","DOI":"10.1073\/pnas.94.20.10850","article-title":"Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide","volume":"94","author":"Craiu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2023.101766_bib372","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.4049\/jimmunol.159.12.5896","article-title":"Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation","volume":"159","author":"Benham","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib373","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.immunol.17.1.739","article-title":"Degradation of cell proteins and the generation of MHC class I-presented peptides","volume":"17","author":"Rock","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib374","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-065X.1999.tb01355.x","article-title":"Proteolysis and class I major histocompatibility complex antigen presentation","volume":"172","author":"York","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2023.101766_bib375","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/emboj\/20.10.2357","article-title":"26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.","volume":"20","author":"Cascio","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.smim.2023.101766_bib376","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.194.1.1","article-title":"Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.","volume":"194","author":"Toes","year":"2001","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib377","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0161-5890(02)00098-6","article-title":"The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides","volume":"39","author":"Goldberg","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib378","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0161-5890(02)00102-5","article-title":"Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases","volume":"39","author":"Saveanu","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib379","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.0903399","article-title":"Proteases in MHC class I presentation and cross-presentation.","volume":"184","author":"Rock","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib380","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2009.10.009","article-title":"Thymoproteasome shapes immunocompetent repertoire of CD8+ T cells","volume":"32","author":"Nitta","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2023.101766_bib381","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00018-011-0657-y","article-title":"The role of the proteasome in the generation of MHC class I ligands and immune responses","volume":"68","author":"Sijts","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.smim.2023.101766_bib382","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ni.2203","article-title":"Mice completely lacking immunoproteasomes show major changes in antigen presentation","volume":"13","author":"Kincaid","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib383","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.4049\/jimmunol.1602122","article-title":"Varied role of ubiquitylation in generating MHC class i peptide ligands","volume":"198","author":"Wei","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib384","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41590-018-0186-z","article-title":"The immunoproteasome and thymoproteasome: functions, evolution and human disease","volume":"19","author":"Murata","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib385","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/89800","article-title":"ER aminopeptidases generate a unique pool of peptides for MHC class I molecules","volume":"2","author":"Serwold","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib386","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature01074","article-title":"ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum","volume":"419","author":"Serwold","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib387","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni1208","article-title":"Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum","volume":"6","author":"Saveanu","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib388","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ni859","article-title":"An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides","volume":"3","author":"Saric","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib389","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ni860","article-title":"The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues","volume":"3","author":"York","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib390","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ni1286","article-title":"The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules","volume":"7","author":"Hammer","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib391","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.immuni.2007.04.003","article-title":"The final touches make perfect the peptide-MHC class I repertoire","volume":"26","author":"Hammer","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2023.101766_bib392","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.immuni.2006.09.012","article-title":"ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum","volume":"25","author":"Kanaseki","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2023.101766_bib393","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.2174\/1381612811319220018","article-title":"Inhibitors of the immunoproteasome: current status and future directions","volume":"19","author":"Miller","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.smim.2023.101766_bib394","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.humimm.2019.01.003","article-title":"Peptide trimming by endoplasmic reticulum aminopeptidases: Role of MHC class I binding and ERAP dimerization","volume":"80","author":"Evnouchidou","year":"2019","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib395","first-page":"31","article-title":"Trimming of MHC Class I Ligands by ERAP Aminopeptidases","volume":"2019","author":"Weimershaus","year":"1988","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib396","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0952-7915(95)80031-X","article-title":"Supply and transport of peptides presented by class I MHC molecules","volume":"7","author":"Howard","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib397","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4049\/jimmunol.160.1.171","article-title":"Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction.","volume":"160","author":"Neisig","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib398","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700248","article-title":"Cell Surface MHC Class I Expression Is Limited by the Availability of Peptide-Receptive \u201cEmpty\u201d Molecules Rather than by the Supply of Peptide Ligands","volume":"18","author":"Komov","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2023.101766_bib399","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4049\/jimmunol.161.1.112","article-title":"Proteasomes Can Either Generate or Destroy MHC Class I Epitopes: Evidence for Nonproteasomal Epitope Generation in the Cytosol","volume":"161","author":"Luckey","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib400","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.8342042","article-title":"Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter","volume":"261","author":"Neefjes","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib401","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1084\/jem.179.5.1613","article-title":"Peptide size selection by the major histocompatibility complex-encoded peptide transporter.","volume":"179","author":"Momburg","year":"1994","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2023.101766_bib402","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1073\/pnas.88.22.10094","article-title":"Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region","volume":"88","author":"Bahram","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib403","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/eji.200838136","article-title":"Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry","volume":"38","author":"Weinzierl","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib404","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00424-006-0083-4","article-title":"Intracellular peptide transporters in human--compartmentalization of the \u201cpeptidome\u201d","volume":"453","author":"Herget","year":"2007","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.smim.2023.101766_bib405","doi-asserted-by":"crossref","first-page":"9135","DOI":"10.1073\/pnas.1001308107","article-title":"Single residue within the antigen translocation complex TAP controls the epitope repertoire by stabilizing a receptive conformation","volume":"107","author":"Baldauf","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib406","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1242\/jcs.060632","article-title":"The transporter associated with antigen processing (TAP) is active in a post-ER compartment.","volume":"123","author":"Ghanem","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.smim.2023.101766_bib407","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.molimm.2014.06.006","article-title":"Dominant contribution of the proteasome and metalloproteinases to TAP-independent MHC-I peptide repertoire","volume":"62","author":"Oliveira","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib408","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.molimm.2021.12.013","article-title":"Spotlight on TAP and its vital role in antigen presentation and cross-presentation","volume":"142","author":"Mantel","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib409","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbpa.2018.11.001","article-title":"Regulation of phagosome functions by post-translational modifications: a new paradigm","volume":"48","author":"Dean","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib410","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108970","article-title":"The E3 ubiquitin ligase RNF115 regulates phagosome maturation and host response to bacterial infection.","volume":"41","author":"Bilkei-Gorzo","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.smim.2023.101766_bib411","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ni985","article-title":"Enhancement of CIITA transcriptional function by ubiquitin","volume":"4","author":"Greer","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib412","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/JVI.78.3.1109-1120.2004","article-title":"Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins.","volume":"78","author":"Bartee","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2023.101766_bib413","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1074\/mcp.M900174-MCP200","article-title":"Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase","volume":"8","author":"H\u00f6r","year":"2009","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib414","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0854.2009.01011.x","article-title":"Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains","volume":"11","author":"Boname","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.smim.2023.101766_bib415","doi-asserted-by":"crossref","first-page":"25893","DOI":"10.1074\/jbc.M110.127746","article-title":"Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.","volume":"285","author":"Bhat","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2023.101766_bib416","doi-asserted-by":"crossref","first-page":"20465","DOI":"10.1073\/pnas.1010990107","article-title":"Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells","volume":"107","author":"Walseng","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib417","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1073\/pnas.0708874105","article-title":"MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation","volume":"105","author":"De Gassart","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.smim.2023.101766_bib418","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/icb.2017.44","article-title":"MARCH9-mediated ubiquitination regulates MHC I export from the TGN","volume":"95","author":"De Angelis Rigotti","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.smim.2023.101766_bib419","first-page":"259","article-title":"Monitoring MHC ubiquitination by MARCH ubiquitin ligases","volume":"2019","author":"Gatti","year":"1988","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.smim.2023.101766_bib420","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/349669a0","article-title":"Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments","volume":"349","author":"Peters","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib421","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.4049\/jimmunol.162.6.3263","article-title":"Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes","volume":"162","author":"Ramachandra","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib422","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V","article-title":"On cross-priming of MHC class I-specific CTL: rule or exception?","volume":"32","author":"Zinkernagel","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib423","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature01912","article-title":"Phagosomes are competent organelles for antigen cross-presentation","volume":"425","author":"Houde","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib424","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature01911","article-title":"ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells","volume":"425","author":"Guermonprez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib425","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00281-004-0176-0","article-title":"Pathways for antigen cross presentation","volume":"26","author":"Guermonprez","year":"2005","journal-title":"Springe Semin. Immunopathol."},{"key":"10.1016\/j.smim.2023.101766_bib426","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2009.01.001","article-title":"MHC molecules and microbial antigen processing in phagosomes","volume":"21","author":"Ramachandra","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib427","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41568-021-00344-2","article-title":"Autophagy in tumour immunity and therapy","volume":"21","author":"Xia","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.smim.2023.101766_bib428","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.628429","article-title":"The macroautophagy machinery in MHC restricted antigen presentation","volume":"12","author":"M\u00fcnz","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib429","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.7809629","article-title":"A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules","volume":"267","author":"Kovacsovics-Bankowski","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib430","doi-asserted-by":"crossref","first-page":"12889","DOI":"10.1073\/pnas.1735556100","article-title":"Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens","volume":"100","author":"Ackerman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2023.101766_bib431","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.2007.00552.x","article-title":"Phagocytosis and antigen presentation in dendritic cells","volume":"219","author":"Savina","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2023.101766_bib432","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2014.04.054","article-title":"TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation","volume":"158","author":"Nair-Gupta","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.smim.2023.101766_bib433","first-page":"1513","article-title":"The ER phagosome connection in the era of membrane contact sites","volume":"2017","author":"Nunes-Hasler","year":"1864","journal-title":"Biochim. Biophys. Acta Mol. Cell Res"},{"key":"10.1016\/j.smim.2023.101766_bib434","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100116","article-title":"MS-based HLA-II peptidomics combined with multiomics will aid the development of future immunotherapies","volume":"20","author":"Taylor","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.smim.2023.101766_bib435","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/eji.200323730","article-title":"Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy","volume":"33","author":"Nimmerjahn","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib436","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib437","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030185","article-title":"Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation","volume":"3","author":"Blach\u00e8re","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.smim.2023.101766_bib438","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.286.5441.952","article-title":"TCR-Mediated internalization of peptide-MHC complexes acquired by T cells","volume":"286","author":"Huang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.smim.2023.101766_bib439","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ni0903-815","article-title":"What is trogocytosis and what is its purpose","volume":"4","author":"Joly","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib440","article-title":"Gnawing between cells and cells in the immune system: friend or foe? a review of trogocytosis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib441","doi-asserted-by":"crossref","first-page":"1053582","DOI":"10.3389\/fimmu.2022.1053582","article-title":"Intracellular monitoring by dendritic cells - a new way to stay informed - from a simple scavenger to an active gatherer","volume":"13","author":"Herbst","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib442","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1054-1","article-title":"CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape","volume":"568","author":"Hamieh","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.smim.2023.101766_bib443","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1158\/1535-7163.MCT-19-1109","article-title":"Shaping functional avidity of CAR T cells: affinity, avidity, and antigen density that regulate response","volume":"20","author":"Greenman","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.smim.2023.101766_bib444","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/1535-7163.MCT-19-1110","article-title":"Phenotypic models of CAR T-cell activation elucidate the pivotal regulatory role of CAR downmodulation","volume":"20","author":"Greenman","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.smim.2023.101766_bib445","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4049\/jimmunol.0900861","article-title":"Direct antigen presentation and gap junction mediated cross-presentation during apoptosis.","volume":"183","author":"Pang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2023.101766_bib446","doi-asserted-by":"crossref","first-page":"318ra200","DOI":"10.1126\/scitranslmed.aac9816","article-title":"The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection","volume":"7","author":"Dieud\u00e9","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2023.101766_bib447","doi-asserted-by":"crossref","first-page":"44ra57","DOI":"10.1126\/scitranslmed.3000739","article-title":"Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity","volume":"2","author":"Saccheri","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2023.101766_bib448","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1198865","article-title":"Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway","volume":"5","author":"Duvallet","year":"2016","journal-title":"Oncoimmunology"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453232300057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453232300057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:25:57Z","timestamp":1777605957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104453232300057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":448,"alternative-id":["S104453232300057X"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2023.101766","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The biogenesis of the immunopeptidome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2023.101766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101766"}}